US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

38.61

-0.1263-0.33%

Volume:62.36K

Turnover:2.39M

Market Cap:260.64M

PE:- -

High:38.61

Open:38.55

Low:38.17

Close:38.74

52wk High:41.49

52wk Low:22.33

Shares:6.75M

Float Shares:6.75M

Volume Ratio:0.57

T/O Rate:0.92%

Dividend:0.28

Dividend Rate:0.73%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Celcuity To Participate in Upcoming Investor Conferences

Moderna to Present at Morgan Stanley Global Healthcare Conference

Satellos to Participate in Upcoming Investor Conferences

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Incyte (INCY) and Eli Lilly & Co (LLY)

Novartis halts autoimmune CAR-T trials following three deaths, Reuters says

Revolution Medicines Signs Long-Term Headquarters Lease Agreement

Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs

Revolution Medicines (RVMD) Could Be 7% Below Fair Value On FDA Approval Of RASONQUE

Simply Wall St.

Top 10 Best-Performing US Stocks in August: Moderna Surges 156%, Palantir Leads AI Software Stocks

Vertex Advances Share Buyback, Acquires 445,500 Shares by August

Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run

Simply Wall St.

Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s Disease

Incyte Reaches CMS Pact on Jakafi Medicaid Pricing

NeuroThera Labs Advances Enrollment in Autism Drug Trial for SCI-210

Incyte - Expects Exemption from Future CMS Pricing Mandates Including Guard and Globe - SEC Filing

THOMSON REUTERS

Incyte - Announces Agreement with CMS to Improve Medicine Access - SEC Filing

THOMSON REUTERS

Incyte - State Medicaid to Access Jakafi and Jakafi Xr at Prices Aligned with Advanced Nations - SEC Filing

THOMSON REUTERS

Incyte - Does not Expect Agreement to Affect 2026 Financial Guidance or Outlook - SEC Filing

THOMSON REUTERS

SciSparc subsidiary provides update on SCI-210 trial enrollment

PMV Pharmaceuticals announces updated ovarian cancer data from PYNNACLE trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/IDNA/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IDNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","market":"US","secType":"STK","nameCN":"iShares Genomics Immunology and Healthcare ETF","latestPrice":38.6137,"timestamp":1789492657632,"preClose":38.74,"halted":0,"volume":62359,"delay":0,"changeRate":-0.0032601961796592804,"floatShares":6750000,"shares":6750000,"eps":0,"marketStatus":"Trading","change":-0.1263,"latestTime":"09-15 13:20:38 EDT","open":38.549,"high":38.6137,"low":38.165,"amount":2391311.253628,"amplitude":0.011582,"askPrice":38.64,"askSize":300,"bidPrice":38.39,"bidSize":300,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":38.74,"sharesOutstanding":5100000,"nav":37.991633,"aum":258343104.4,"dividendRate":0.007324,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":38.74,"preClose":38.74,"latestTime":"19:30 EDT","volume":75,"amount":2918.7,"timestamp":1789428601745,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.570173,"impliedVol":0.2015,"impliedVolPercentile":0.5219},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","floatShares":6750000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.570173,"shares":6750000,"dividePrice":0.2828,"high":38.6137,"amplitude":0.011582,"preClose":38.74,"low":38.165,"week52Low":22.33,"pbRate":"--","week52High":41.49,"institutionHeld":0,"latestPrice":38.6137,"eps":0,"divideRate":0.007324,"volume":62359,"delay":0,"ttmEps":0,"open":38.549,"prevYearClose":26.19,"prevWeekClose":38.06,"prevMonthClose":39.26,"prevQuarterClose":33.75,"fiveDayClose":39.23,"twentyDayClose":35.86,"sixtyDayClose":30.56},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDNA\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IDNA","amount":0.125421,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2025-12-16","symbol":"IDNA","amount":0.155456,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"IDNA","amount":0.152909,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"IDNA","amount":0.11105,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"IDNA","amount":0.11144,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDNA\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-16","recordDate":"2019-12-17","paymentDate":"2019-12-20","value":0.237063,"currency":"USD"},{"executeDate":"2020-06-15","recordDate":"2020-06-16","paymentDate":"2020-06-19","value":0.083667,"currency":"USD"},{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-18","value":0.036209,"currency":"USD"},{"executeDate":"2021-06-10","recordDate":"2021-06-11","paymentDate":"2021-06-16","value":0.052145,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-17","value":0.256358,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDNA\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664851222","title":"Celcuity To Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664851222","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664851222?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:30","pubTimestamp":1788265800,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS, Sept.  01, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354143/0/en/celcuity-to-participate-in-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","IDNA","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664083853","title":"Moderna to Present at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664083853","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664083853?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:06","pubTimestamp":1788260801,"startTime":"0","endTime":"0","summary":"Moderna to present at Morgan Stanley Global Healthcare ConferenceModerna will present at the Morgan Stanley Global Healthcare Conference on Sept. 14, 2026 at 10:00 a.m. ET.It will also present at the ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL8XX49W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1732799900.SGD","GNOM","LU1720051017.SGD","LU0106831901.USD","MRNX","LU0390134368.USD","BK4533","LU2023251221.USD","BK4501","LU1244550577.SGD","IDNA","WDNA","BK4581","BK4504","LU0795875086.SGD","LU1988902786.USD","LGHT","LU2028103732.USD","LU0882574139.USD","LU0528227936.USD","LU2264538146.SGD","BK4548","LU0225283273.USD","LU0320765646.SGD","LU1791710400.SGD","LU0267386448.USD","LU1791710582.SGD","LU2357305700.SGD","LU0912757837.SGD","LU2347655156.SGD","IE00BZ1G4Q59.USD","BK4588","LU0158827948.USD","MRNA","LU0106261372.USD","BK4585","LU1548497426.USD","BK4516","LU0557290698.USD","KBWB","BK4532","LU0795875169.SGD","LU1720051108.HKD","LU1989772840.SGD","LU1989772923.USD","LU2111349929.HKD","LU1064131342.USD","IE00B775SV38.USD","MRNY","IAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664085583","title":"Satellos to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664085583","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664085583?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:00","pubTimestamp":1788260400,"startTime":"0","endTime":"0","summary":"TORONTO, Sept.  01, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage drug development company developing life-improving medicines to treat degenerative mus","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3353948/0/en/satellos-to-participate-in-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","MEDX","GDOC","NVIB","BK4139","IDNA","MSLE","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664853142","title":"Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Incyte (INCY) and Eli Lilly & Co (LLY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664853142","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664853142?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:50","pubTimestamp":1788259807,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immunic (IMUX), Incyte (INCY) and Eli Lilly & Co (LL...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immunic-imux-incyte-incy-and-eli-lilly-co-lly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immunic-imux-incyte-incy-and-eli-lilly-co-lly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999015978.USD","JDOC","LU2089284900.SGD","LU2237443622.USD","LU2236285917.USD","BK4007","WDNA","LU1093756168.USD","LU2168563687.JPY","LU0174119429.USD","IE00B1BXHZ80.USD","LU2461242641.AUD","SG9999001176.USD","LU0964807845.USD","IHE","LU1629891620.HKD","IE00B4JS1V06.HKD","SG9999017495.SGD","LU2456880835.USD","LU2168564222.USD","IE00B1XK9C88.USD","LU0266013472.USD","LU2746668461.USD","IXJ","LU0198837287.USD","LU2471134523.USD","LU2756315318.SGD","LU0109391861.USD","LU2471134796.USD","SG9999015952.SGD","IE00BJJMRY28.SGD","LU0708995401.HKD","LU0354030511.USD","IE00BFSS7M15.SGD","LU0823434740.USD","SG9999015986.USD","LU0820562030.AUD","LU0882574139.USD","LU0417517546.SGD","LU2265009873.SGD","LU0820561909.HKD","LU0079474960.USD","LU0238689110.USD","IE0004445015.USD","LU2750360641.GBP","LU0823416689.USD","IE00B2B36J28.USD","IE00BKDWB100.SGD","LU1979441026.SGD","LU0353189763.USD","LU2111349929.HKD","LU1551013342.USD","CURE","LU2028103732.USD","LU0889565916.HKD","LU2491050071.SGD","IE00BK4W5M84.HKD","LU0289739699.SGD","LU1868837300.USD","LU2089283258.USD","LU1720051017.SGD","BK4585","IE00BJJMRZ35.SGD","LU0689472784.USD","VHT","MHIP","IE0005OL40V9.USD","IE0002141913.USD","CANC","MEDX","BK4532","LU0466842654.USD","BK4581","LU2462591350.SGD","LU0203201768.USD","IE00BJJMRX11.SGD","FHLC","LU0114720955.EUR","LU0158827781.USD","FTXH","IE00BKPKM429.USD","LU0109394709.USD","LU0320765059.SGD","LU0385154629.USD","LU0203202063.USD","LU0432979614.USD","BK4588","LU0471298694.HKD","LU1868836757.USD","LU1989771016.USD","LU2063271972.USD","LU2756315664.SGD","LU1548497426.USD","LU1691799644.USD","LU1232071149.USD","LU2213496289.HKD","SG9999014906.USD","PJP","LLYX","LU1983299246.USD","IDNA","LU0345770308.USD","LU0943347566.SGD","LU2360106947.USD","IYH","SGXZ57979304.SGD","SG9999013999.USD","IE00BJLML261.HKD","LU0006306889.USD","LU1035775433.USD","ELIS","LU0256863811.USD","RXL","SG9999018865.SGD","LU1804176565.USD","LU0061475181.USD","LU0158827948.USD","LU0323591593.USD","LU2361044949.HKD","LU0133085943.USD","LU2087625088.SGD","LU1061106388.HKD","LU0096364046.USD","LU2361045086.USD","IE0009355771.USD","ELIL","LU2271345857.HKD","LU2552382058.USD","LU1057294990.SGD","LU1720051108.HKD","LU2237443895.HKD","SG9999015945.SGD","TMED","LU2237443465.HKD","LU0823434583.USD","GB00BDT5M118.USD","LU0456855351.SGD","LU0787776722.HKD","LU2468319806.SGD","LU2357305700.SGD","LU1069344957.HKD","LU1291159041.SGD","LU1280957306.USD","LU2471134952.CNY","LU1366192091.USD","ILDR","LU1145028129.USD","LU1974910355.USD","LU0345770993.USD","LU2237443549.SGD","LU2462157665.USD","LU0882574055.USD","IE0004445239.USD","IE00BFSS8Q28.SGD","LU0058720904.USD","LU2602419157.SGD","LU2108987350.USD","MEDI","LU2168564495.EUR","IE00BJT1NW94.SGD","LU0094547139.USD","SG9999014914.USD","LU2023250330.USD","GDOC","LLYZ","SGXZ31699556.SGD","LU0097036916.USD","LU2361044865.SGD","LU1868836914.USD","LU1093756325.SGD","LU2168564149.EUR","BK4534","IE00BWXC8680.SGD","LU2237443978.SGD","LU0354030438.USD","LU2168564065.EUR","LU1623119135.USD","LU2324357040.USD","IMUX","LU1551013425.SGD","HRTS","LU2417539215.USD","LU0353189680.USD","LU1127390331.HKD","SGXZ81514606.USD","BK4599","AGNG","LU2237443382.USD","IE00BK4W5L77.USD","LU2237438978.USD","LU0471298777.SGD","LU2746668974.SGD","LU2750360997.AUD","LU1868836591.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU2552382215.SGD","SG9999001176.SGD","LU0786609619.USD","SGXZ51526630.SGD","LLII","LU0210536198.USD","LU0640476718.USD","SGXZ99366536.SGD","SG9999014880.SGD","LU2106854487.HKD","SG9999014898.SGD","LU1267930730.SGD","LU1712237335.SGD","LU2112291526.USD","LU1814569148.SGD","BK4550","LU0234572021.USD","SG9999018857.SGD","LU1323610961.USD","LU1023059063.AUD","BK4516","LU0683600562.USD","LU2023250504.SGD","LU0672654240.SGD","LLY","LU1917777945.USD","LU0256863902.USD","BK4139","LU1868837136.USD","PPH","TRUH","LU0820561818.USD","IE00B7KXQ091.USD","LU2491050154.USD","OZEM","LU0122379950.USD","LU2491049909.HKD","LU2089984988.USD","LU2471134879.HKD","LU2896262040.SGD","LU2023251221.USD","LU2552382132.HKD","BK4533","IE00B775H168.HKD","LU0316494557.USD","IE00BN29S564.USD","LU0225283273.USD","LU1988902786.USD","LU2211815571.USD","IE00B4R5TH58.HKD","LU2264538146.SGD","INCY","LU0106261372.USD","LU1064131342.USD","THNR","IE0001KFT4U8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664985383","title":"Novartis halts autoimmune CAR-T trials following three deaths, Reuters says","url":"https://stock-news.laohu8.com/highlight/detail?id=2664985383","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664985383?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:30","pubTimestamp":1788258648,"startTime":"0","endTime":"0","summary":"Novartis (NVS) has paused eight clinical trials of rap-cel, an experimental cell therapy targeting autoimmune and neurological disorders, after thr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-halts-autoimmune-car-t-trials-following-three-deaths-reuters-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-halts-autoimmune-car-t-trials-following-three-deaths-reuters-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVS","LU0211331839.USD","GNOM","BK4007","CNCR","BK4578","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BK4588","IE0009355771.USD","GDOC","BK4585","BMED","LU0320765489.SGD","IE00B4R5TH58.HKD","TBXU","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0070302665.USD","SYNB","LU0208291251.USD","NVIB","IBB","IE0002141913.USD","MEDX","FBT","BK4532","LFSC","IDNA","IBBQ","PPH","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664538548","title":"Revolution Medicines Signs Long-Term Headquarters Lease Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2664538548","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664538548?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:29","pubTimestamp":1788258558,"startTime":"0","endTime":"0","summary":"Revolution Medicines ( ($RVMD) ) has provided an announcement. On August 27, 2026, Revolution Medicines agreed to lease four buildings totaling abo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/revolution-medicines-signs-long-term-headquarters-lease-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/revolution-medicines-signs-long-term-headquarters-lease-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE0002141913.USD","CANC","BK4139","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IDNA","IE0009354923.USD","LU0320765992.SGD","LU0889565916.HKD","RVMD","PTH","IE00BJJMRZ35.SGD","LU0109394709.USD","BBH","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664287830","title":"Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2664287830","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664287830?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:40","pubTimestamp":1788255621,"startTime":"0","endTime":"0","summary":"Goldman Sachs analysts added Vertex Pharmaceuticals (VRTX) to the firm’s US Conviction List as part of its monthly update. Goldman believes Vertex ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-added-to-us-conviction-list-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-added-to-us-conviction-list-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2362540622.SGD","GSX","LU2471134879.HKD","LU0106831901.USD","LU1430594728.SGD","IE00BZ9MQY76.HKD","IE0034235188.USD","IE00B2B36J28.USD","VRTX","LU1093756325.SGD","GNMX","LU2471134796.USD","LU1778281490.HKD","BIB","LU0345770993.USD","LU1035775433.USD","BBH","IE00BFTCPJ56.SGD","LU1585245621.USD","IE00B894F039.SGD","LU2236285917.USD","IBB","LU2237443382.USD","LU2362541273.HKD","LU2362541513.USD","IDNA","BK4504","PBE","BK4127","VERX","IE00B19Z3581.USD","LU2089984988.USD","LU0432979614.USD","IE0004091025.USD","IE0002141913.USD","LU0868494708.USD","LU2471134952.CNY","LU1815336091.USD","IE0002270589.USD","IE00BSNM7G36.USD","LU0417517546.SGD","LU2237443895.HKD","SGXZ57979304.SGD","LU0757428866.USD","TBXU","IBBQ","LU1894683264.USD","LU1668664300.SGD","IE00BJT1NW94.SGD","LU1868836914.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883781","title":"Revolution Medicines (RVMD) Could Be 7% Below Fair Value On FDA Approval Of RASONQUE","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883781","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883781?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:22","pubTimestamp":1788250932,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) is in focus after the FDA approved RASONQUE, an oral RAS(ON) inhibitor for adults with metastatic pancreatic adenocarcinoma following prior systemic therapy or for those unsuitable for multiagent regimens.\nRevolution Medicines’ share price is around US$205.57 after a slight pullback over the past week. The 30 day share price return of 9.62% and 90 day share price return of 35.86% sit against a year to date share price return of 160.15%, while the 1 year total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rvmd/revolution-medicines/news/revolution-medicines-rvmd-could-be-7-below-fair-value-on-fda","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rvmd/revolution-medicines/news/revolution-medicines-rvmd-could-be-7-below-fair-value-on-fda","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BD6J9T35.USD","LU1861220033.SGD","BK4512","LU1983260115.SGD","LABU","LU0124384867.USD","LU1854103824.USD","BK4605","BBH","IE00B2B36J28.USD","LU2298322129.HKD","IE00BFTCPJ56.SGD","PTH","BK4141","LU1548497426.USD","BK4588","LU0348723411.USD","LU2357305700.SGD","ON","LU1861219969.SGD","IE00B4R5TH58.HKD","LU1861214812.USD","BK4585","LU0109394709.USD","IDNA","IE0009354923.USD","LU1720051108.HKD","LU0320765992.SGD","LU2360107325.USD","IE00BJT1NW94.SGD","IE0002141913.USD","CANC","IE0009355771.USD","IE00BFMHRM44.USD","IE00BJJMRZ35.SGD","LU1854104046.USD","LU1861215975.USD","IE00BZ199S13.USD","LU1720051017.SGD","ONX","LU1978683503.SGD","LU0724618433.USD","RVMD","LU0889565916.HKD","ONG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664836115","title":"Top 10 Best-Performing US Stocks in August: Moderna Surges 156%, Palantir Leads AI Software Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2664836115","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664836115?lang=en_us&edition=fundamental","pubTime":"2026-09-01 14:51","pubTimestamp":1788245470,"startTime":"0","endTime":"0","summary":"TradingKey - In August 2026, the upward momentum in US stocks broadened significantly. Moderna (MRNA) topped the S&P 500 constituents with a 156% gain, surging 375.9% year-to-date. Palantir (PLTR) followed closely behind, rising 51.5% in August, while enterprise software stocks as a whole extended their previous recovery.","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230915/5159981a89101d628f3e4c33ac20272e.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230915/5159981a89101d628f3e4c33ac20272e.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262143172-top-10-best-performing-us-stocks-august-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","LU0109391861.USD","IE00B19Z8W00.USD","BK4568","LU0106261372.USD","SMCZ","SMCX","LU1861559042.SGD","LU0234572021.USD","SNDC","BK4501","LU0648000940.SGD","LU1267930813.SGD","LU0289961442.SGD","LU0642271901.SGD","LU0316494557.USD","CRM","IE00BZ9MQY76.HKD","LU0055631609.USD","LU1496350171.SGD","LU1430597077.USD","PLTU","LGHT","LU1720051017.SGD","IE00B19Z3581.USD","LU0823434583.USD","LU2498475776.HKD","LU2111349929.HKD","LU0788109121.HKD","SNXX","LU1267930490.SGD","PLYY","IE00BQXX3F31.USD","EKG","LU0310800965.SGD","LU0320765059.SGD","LU0345780521.USD","LU0980610538.SGD","SMCI","LU1201861249.SGD","LU0107464264.USD","LU0082616367.USD","LU0267386448.USD","LU2236285917.USD","LU0130102774.USD","BK4551","LU1223082196.USD","LU0889566641.SGD","LU2125909916.SGD","LU2462611646.USD","LU2517655291.USD","LU1923623000.USD","PLTL","LU0069063385.USD","IE00B19Z9505.USD","BK4548","BK4532","BK4547","LU0557290698.USD","LU1791710400.SGD","LU0630314457.HKD","LU0011850046.USD","IE00B19Z8X17.USD","NOWL","CLOD","LU0251131958.USD","BK4570","LU0048573561.USD","IE00BJTD4V19.USD","LU0052756011.USD","LU0472753341.HKD","LU2461242641.AUD","BK4528","LU0820561909.HKD","LU0889565833.HKD","PLTW","LU0130517989.USD","LU0640476718.USD","LU0724618789.USD","IE00BZ1G4Q59.USD","BK4139","BK4608","LU0823434740.USD","LU0187121727.USD","LU1548497426.USD","LU1267930730.SGD","LU0198837287.USD","SMYY","LU1989764748.USD","NOWX","LU1201861165.SGD","LU0154245756.USD","BK4527","BK4125","PLTI","BK4535","LU0251142724.SGD","SG9999001143.SGD","PLTG","LU0963586101.USD","IE00BMPRXN33.USD","SLVP","PLTA","IE00BKVL7J92.USD","SCHA","LU1551013425.SGD","LU0820562030.AUD","TMSL","IE00B19Z9P08.USD","BK4613","IE00B894F039.SGD","LU2023251221.USD","BK4579","LU0792757196.USD","CNAV","LU0053671581.USD","LU0689472784.USD","BK4585","GUNZ","LU1720051108.HKD","LU1267930227.SGD","MRNX","LU0289739699.SGD","LU0648001328.SGD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0820561818.USD","NEM","LU1116320737.USD","LU0006306889.USD","QQQG","LU0158827948.USD","LU0943347566.SGD","LU0266512127.USD","LU2517655374.HKD","LU2756315664.SGD","LU2362541513.USD","LU0689626769.HKD","LU1804176565.USD","AIPI","LU1988902786.USD","IE00B19Z9Z06.USD","LU1861558580.USD","MRNA","LU0314104364.USD","LU0127658192.USD","IE00BQXX3D17.EUR","LU1064131342.USD","LU0266013472.USD","LU0330918003.SGD","LU1923622614.USD","LU0353189763.USD","FSMD","IE00BMPRXR70.SGD","LU2361044865.SGD","LU1917777945.USD","LU0211328371.USD","LU2381873111.SGD","LU2271345857.HKD","GDX","BK4566","LU2125909593.SGD","LU0310799852.SGD","LU0054578231.USD","PTIR","BK4167","TRUM","SGDM","LU0612318385.USD","LU0612318971.USD","LU1323610961.USD","LU0354030438.USD","BK4534","IE00BJTD4N35.SGD","LU2089284900.SGD","LU1951198990.SGD","LU2063271972.USD","LU0477156797.USD","LU0498741114.HKD","LU2360107168.USD","PTF","LU2023250504.SGD","BK4504","LU0109392836.USD","LU2290526834.HKD","LU0130518102.USD","LU2362540622.SGD","LU2458330169.SGD","PLTY","IGV","EYES","LU0158827781.USD","SNDU","LU1823568750.SGD","LU1791710582.SGD","LU1496350502.SGD","LU2106854487.HKD","LU1223083913.SGD","LU2543165471.USD","LU2433249047.HKD","PLTR","LU0354030511.USD","LU1280957306.USD","LU2244417387.USD","BK4607","LU0265550359.USD","BK4588","LU2362541273.HKD","LU0788108826.HKD","LU0345780281.USD","LU0708995401.HKD","CRMG","LU0300736062.USD","LU1861215975.USD","LU0368265764.SGD","PLTD","LU0265550946.USD","PLTZ","BK4581","LU0345781412.USD","LU2023250843.SGD","BK4017","LU0345780950.USD","BK4503","LU1366333091.USD","VEEV","NOW","BK4543","BK4134","LU0130103400.USD","LU2756315318.SGD","LU0154245673.USD","SMCC","LU2361044949.HKD","LU0211327993.USD","WDNA","LU2125909759.SGD","NEMG","LU0498741890.SGD","SNDQ","LU0266512473.USD","BK4023","LU0081259029.USD","LU0348723411.USD","SNDK","SPLTRmain","LU2357305700.SGD","LU0742534661.SGD","BK4505","LU2125909247.SGD","LU0170899867.USD","COWG","LU0234570918.USD","BK4561","LU1974910355.USD","LU1923622291.USD","AUAU","PSKY","LU1989772840.SGD","LU0496367417.USD","LU0300736492.USD","LU0654597011.USD","LU1883866441.USD","LU0477156953.USD","BK4567","LU2028103732.USD","SHLD","LU2265009873.SGD","LU1316542783.SGD","LU0528227936.USD","GNOM","PLOO","SMCY","LU0124676726.USD","LU0058720904.USD","LU1951200564.SGD","LU2089283258.USD","LU0278409577.USD","BK4598","LU0672654240.SGD","BK4550","BK4097","LU1803068979.SGD","SMCL","LU2247934214.USD","NWMX","BK4170","GDMN","LU0289739343.SGD","IE00BQXX3C00.GBP","SCHM","OPTZ","LU1861220033.SGD","LU2087625088.SGD","LU0128525689.USD","LU0238689110.USD","BK4538","LU1814569148.SGD","LU1223082519.USD","PLT","BK4533","LU0456854461.SGD","IT","LU0157215616.USD","LU0353189680.USD","LU2361045086.USD","LU1046421795.USD","LU0511384066.AUD","FMTL","FCUS","LU1116320901.HKD","LU2286300806.USD","MRNY","LU0057025933.USD","SNDG","LU1989772923.USD","DISK","LU0075056555.USD","LU2458330243.SGD","LU1989764664.SGD","LU2264538146.SGD","LU1551013342.USD","LU1235294995.USD","AGMI","LU2517655028.SGD","LU1153585028.USD","LU0719512351.SGD","LU1023059493.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838571","title":"Vertex Advances Share Buyback, Acquires 445,500 Shares by August","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838571","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838571?lang=en_us&edition=fundamental","pubTime":"2026-09-01 12:22","pubTimestamp":1788236545,"startTime":"0","endTime":"0","summary":"Vertex Corp. ( ($JP:5290) ) has provided an announcement. Vertex Corporation reported the progress of its ongoing share buyback program, authorized...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-advances-share-buyback-acquires-445500-shares-by-august?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-advances-share-buyback-acquires-445500-shares-by-august?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BRKL","IE0002141913.USD","LU0889565916.HKD","BRKW","LU2462157665.USD","VRTX","LU1674673428.USD","ACKY","LU1778281490.HKD","LU0109394709.USD","BBH","LU0234570918.USD","IDNA","LU0320765992.SGD","BRKU","LU0061475181.USD","PBE","LU0757428866.USD","VERX","LU1035775433.USD","BRKD","BK4567","IBB","IE00B2B36J28.USD","BK4588","LU1559883803.SGD","BK4139","IE00BZ9MQY76.HKD","LU0058720904.USD","GNMX","IE00BJT1NW94.SGD","LU2237438978.USD","LU1069344957.HKD","LU0256863811.USD","LU0417517546.SGD","LU1585245621.USD","LU1430594728.SGD","LU1815336091.USD","IE00B19Z9P08.USD","TBXU","ACTV","LU2362541513.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","BIB","IBBQ","BRKC","LU2468319806.SGD","SG9999001176.USD","LU2456880835.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838493","title":"Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838493","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838493?lang=en_us&edition=fundamental","pubTime":"2026-09-01 10:20","pubTimestamp":1788229256,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals has delivered strong long term gains over the past five years, yet current valuation checks suggest the stock now looks closer to fairly priced than clearly cheap. For investors, the question is how that past share price performance lines up with what the broader valuation signals are saying today.\n\nThe stock has returned 174.9% over five years, which puts extra focus on whether recent strength already reflects much of the good news in the story.\nFuture growth in cash...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/vertex-vrtx-stock-looks-reasonable-as-growth-must-justify-it","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/vertex-vrtx-stock-looks-reasonable-as-growth-must-justify-it","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VERX","IE00B2B36J28.USD","BK4588","IE00BJJMRZ35.SGD","VRTX","GNMX","PBE","LU0289739699.SGD","LU1035775433.USD","SG9999001176.USD","LU1674673691.USD","IE0009355771.USD","LU2362540622.SGD","LU2089984988.USD","LU2324357040.USD","LU0109394709.USD","IE0002141913.USD","TACU","LU0234570918.USD","IE00BZ9MQY76.HKD","TBXU","LU1093756168.USD","IBB","LU2417539215.USD","TSPA","BK4139","LU1778281490.HKD","BK4532","IE00B19Z3B42.SGD","SGXZ57979304.SGD","LU1430594728.SGD","LU1559883803.SGD","BIB","LU1674673428.USD","LU1815336091.USD","LU1069344957.HKD","IE00B19Z9Z06.USD","LU0061475181.USD","SG9999001176.SGD","IBBQ","CDIG","LU0432979614.USD","IDNA","IE00B19Z3581.USD","LU0079474960.USD","LU0566484027.USD","BK4585","LU0823416689.USD","BBH","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664881893","title":"Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2664881893","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664881893?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:30","pubTimestamp":1788219000,"startTime":"0","endTime":"0","summary":"An Important Step Forward for Access to LEQEMBI for Eligible Patients in CanadaTOKYO and CAMBRIDGE, Mass., Aug.  31, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB), announced ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/31/3353756/0/en/canada-s-drug-agency-issues-final-positive-recommendation-supporting-public-reimbursement-of-leqembi-lecanemab-for-early-alzheimer-s-disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","MCI","MEDX","NVIB","HYLG","SOCL","GDOC","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883783","title":"Incyte Reaches CMS Pact on Jakafi Medicaid Pricing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883783","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883783?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:47","pubTimestamp":1788209252,"startTime":"0","endTime":"0","summary":"An announcement from Incyte ( ($INCY) ) is now available. Incyte Corporation said it has entered into an agreement with the U.S. Centers for Medica...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/incyte-reaches-cms-pact-on-jakafi-medicaid-pricing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/incyte-reaches-cms-pact-on-jakafi-medicaid-pricing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4532","BK4585","BK4550","IDNA","BK4139","INCY","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883188","title":"NeuroThera Labs Advances Enrollment in Autism Drug Trial for SCI-210","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883188","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883188?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:37","pubTimestamp":1788208671,"startTime":"0","endTime":"0","summary":"NeuroThera Labs Inc. ( ($TSE:NTLX) ) has issued an update. NeuroThera Labs reported strong enrollment momentum in its SCI-210 clinical trial for ch...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurothera-labs-advances-enrollment-in-autism-drug-trial-for-sci-210?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurothera-labs-advances-enrollment-in-autism-drug-trial-for-sci-210?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","GDOC","HYLG","NVIB","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883375","title":"Incyte - Expects Exemption from Future CMS Pricing Mandates Including Guard and Globe - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883375","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883375?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:30","pubTimestamp":1788208211,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0UW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4585","INCY","IDNA","BK4550","BK4139","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883311","title":"Incyte - Announces Agreement with CMS to Improve Medicine Access - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883311","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883311?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:30","pubTimestamp":1788208211,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0UW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4550","BK4532","BK4585","BK4139","BK4588","INCY","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883310","title":"Incyte - State Medicaid to Access Jakafi and Jakafi Xr at Prices Aligned with Advanced Nations - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883310","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883310?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:30","pubTimestamp":1788208211,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0UW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4550","BK4532","BK4588","IDNA","BK4585","BK4139","INCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664314883","title":"Incyte - Does not Expect Agreement to Affect 2026 Financial Guidance or Outlook - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664314883","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664314883?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:30","pubTimestamp":1788208211,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0UW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INCY","BK4550","BK4588","BK4139","BK4585","BK4532","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883858","title":"SciSparc subsidiary provides update on SCI-210 trial enrollment","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883858","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883858?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:10","pubTimestamp":1788207046,"startTime":"0","endTime":"0","summary":"SciSparc (SPRC)announced that NeuroThera Labs continued advancement in participant enrollment for the clinical trial assessing NeuroThera’s SCI-210...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scisparc-subsidiary-provides-update-on-sci-210-trial-enrollment-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scisparc-subsidiary-provides-update-on-sci-210-trial-enrollment-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","HYLG","BK4007","MEDX","NVIB","SPRC","IDNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664831883","title":"PMV Pharmaceuticals announces updated ovarian cancer data from PYNNACLE trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2664831883","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664831883?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:05","pubTimestamp":1788206710,"startTime":"0","endTime":"0","summary":"PMV Pharmaceuticals (PMVP) announced updated interim ovarian cancer data from the Phase 2 pivotal portion of the PYNNACLE clinical trial. The multi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pmv-pharmaceuticals-announces-updated-ovarian-cancer-data-from-pynnacle-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pmv-pharmaceuticals-announces-updated-ovarian-cancer-data-from-pynnacle-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PMVP","NVIB","MEDX","GDOC","BK4139","HYLG","IDNA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}